These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Relationship of immunosuppression to Epstein-Barr viral load and lymphoproliferative disease in pediatric heart transplant patients. Schubert S, Renner C, Hammer M, Abdul-Khaliq H, Lehmkuhl HB, Berger F, Hetzer R, Reinke P. J Heart Lung Transplant; 2008 Jan; 27(1):100-5. PubMed ID: 18187094 [Abstract] [Full Text] [Related]
5. Epstein-Barr virus load for early detection of lymphoproliferative disorder in pediatric renal transplant recipients. Ishihara M, Tanaka E, Sato T, Chikamoto H, Hisano M, Akioka Y, Dohno S, Maeda A, Hattori M, Wakiguchi H, Fujieda M. Clin Nephrol; 2011 Jul; 76(1):40-8. PubMed ID: 21722604 [Abstract] [Full Text] [Related]
6. Use of cytokine polymorphisms and Epstein-Barr virus viral load to predict development of post-transplant lymphoproliferative disorder in paediatric liver transplant recipients. Lee TC, Savoldo B, Barshes NR, Rooney CM, Heslop HE, Gee AP, Caldwell Y, Scott JD, Goss JA. Clin Transplant; 2006 Jul; 20(3):389-93. PubMed ID: 16824159 [Abstract] [Full Text] [Related]
7. Monitoring of Epstein-Barr virus load and killer T cells in pediatric renal transplant recipients. Sato T, Fujieda M, Maeda A, Tanaka E, Miyamura M, Chikamoto H, Hisano M, Akioka Y, Ishiura Y, Dohno S, Hattori M, Wakiguchi H. Clin Nephrol; 2008 Nov; 70(5):393-403. PubMed ID: 19000539 [Abstract] [Full Text] [Related]
8. The value of prospective monitoring of Epstein-Barr virus DNA in blood samples of pediatric liver transplant recipients. Scheenstra R, Verschuuren EA, de Haan A, Slooff MJ, The TH, Bijleveld CM, Verkade HJ. Transpl Infect Dis; 2004 Mar; 6(1):15-22. PubMed ID: 15225222 [Abstract] [Full Text] [Related]